AI assistant
SUTRO BIOPHARMA, INC. — Director's Dealing 2025
Mar 5, 2025
34319_dirs_2025-03-04_ad003827-8bd9-41e1-aa74-2a6c9ed58001.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SUTRO BIOPHARMA, INC. (STRO)
CIK: 0001382101
Period of Report: 2025-03-01
Reporting Person: ALBINI EDWARD C (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-01 | Common Stock | M | 7875 | — | Acquired | 114618 | Direct |
| 2025-03-01 | Common Stock | M | 17250 | — | Acquired | 131868 | Direct |
| 2025-03-01 | Common Stock | F | 10320 | $1.59 | Disposed | 121548 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-01 | Restricted Stock Unit (RSU) | $ | M | 7875 | Disposed | 2027-03-01 | Common Stock (7875) | Direct |
| 2025-03-01 | Restricted Stock Unit (RSU) | $ | M | 17250 | Disposed | 2028-03-01 | Common Stock (17250) | Direct |
Footnotes
F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
F2: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
F3: The RSUs vest as to 1/4th of the total shares annually beginning on March 1, 2024, subject to continued service through each vesting date.
F4: The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date.